Sox17 Regulates Organ Lineage Segregation of Ventral Foregut Progenitor Cells

Sox17 regulates organ lineage segregation of ventral foregutprogenitor cells

Jason R. Spence1, Alex W. Lange2, Suh-Chin J. Lin1, Klaus H. Kaestner3, Andrew M.Lowy4, Injune Kim5, Jeffrey A. Whitsett2, and James M. Wells*,11 Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, 3333 BurnetAvenue, Cincinnati, OH 45229-3039.2Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue,Cincinnati, OH 45229-3039.3 School of Medicine Department of Genetics, University of Pennsylvania, Philadelphia,Pennsylvania 19104-6145.4 Department of Surgery, UCSD Medical Center, La Jolla, CA 92093-0658.5 Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea 306-701.

SUMMARYThe ventral pancreas, biliary system and liver arise from the posterior ventral foregut, but the cell-intrinsic pathway by which these organ lineages are separated is not known. Here we show that theextrahepatobiliary system shares a common origin with the ventral pancreas and not the liver, aspreviously thought. These pancreatobiliary progenitor cells coexpress the transcription factors Pdx1and Sox17 at e8.5 and their segregation into a Pdx1+ ventral pancreas and a Sox17+ biliaryprimordium is Sox17-dependant. Deletion of Sox17 at e8.5 results in the loss of biliary structuresand ectopic pancreatic tissue in the liver bud and common duct, while Sox17 overexpressionsuppresses pancreas development and promotes ectopic biliary-like tissue throughout the Pdx1+domain. Restricting Sox17+ biliary progenitor cells to the ventral region of the gut requires the notcheffector Hes1. Our results highlight the role of Sox17 and Hes1 in patterning and morphogeneticsegregation of ventral foregut lineages.

Keywordsendoderm; Pdx1; pancreas; biliary; extrahepatic; liver; Hes1; stem cell

INTRODUCTIONThe ventral foregut endoderm of the mammalian embryo is a simple epithelium of severalhundred cells, yet it gives rise to a spectrum of organs and structures including the lungs,thyroid, liver and hepatobiliary system (intrahepatic bile ducts (IHBD), extrahepatic bile ducts(EHBD), common duct, gall bladder, cystic duct) and ventral portions of the pancreas, stomach

© 2009 Elsevier Inc. All rights reserved.*Author for correspondence: [email protected]'s Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customerswe are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resultingproof before it is published in its final citable form. Please note that during the production process errors may be discovered which couldaffect the content, and all legal disclaimers that apply to the journal pertain.

NIH Public AccessAuthor ManuscriptDev Cell. Author manuscript; available in PMC 2010 July 1.

Published in final edited form as:Dev Cell. 2009 July ; 17(1): 62–74. doi:10.1016/j.devcel.2009.05.012.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

and duodenum. Studies indicate that the most anterior part of the ventral foregut gives rise tothyroid and lung whereas the posterior region give rise to the liver, biliary system and theventral pancreas (Fukuda and Mizuno, 1978; Le Douarin, 1968; Le Douarin, 1988; Rosenquist,1971; Tremblay and Zaret, 2005). Several studies have demonstrated how signaling cascadesand transcription factors influence foregut organ specification (see below). However, the exactlineage relationship between the liver, extraheptobiliary system and the ventral pancreas is notclear nor have the cell intrinsic factors been identified that mediate separation of these lineagesfrom a common group of foregut progenitor cells.

Studies using embryonic explants, lineage tracing, gene expression analyses and mousegenetics indicate that several different signaling pathways and transcription factors areinvolved in the specification and development of foregut organs. Foregut explant cultures andgenetics have identified that mesoderm-derived signals, including FGF and BMP ligands, actto pattern the ventral foregut into liver, pancreas and lung (Deutsch et al., 2001; Dong et al.,2007; Gualdi et al., 1996; Jacquemin et al., 2006; Serls et al., 2005; Shin et al., 2007) and inthe separation of the liver and pancreatic lineages (Chung et al., 2008). Other pathwaysimplicated in development of hepatic, pancreatic and biliary systems include the FGF10 andHedgehog signaling pathways (Bhushan et al., 2001; Dong et al., 2007; Manfroid et al.,2007) (Hebrok et al., 2000; Kim and Melton, 1998; Litingtung et al., 1998). A large body ofwork has detailed many transcription factors that are required for specification of individualorgans, including the liver (Foxa2, Foxa1 and Hhex) and pancreas (Ptf1a/p48, Pdx1, Hhex)(Bort et al., 2004; Bort et al., 2006; Kawaguchi et al., 2002; Krapp et al., 1998; Lee et al.,2005; Offield et al., 1996). Despite these significant advances, the cell-intrinsic mechanismsby which this common pool of foregut progenitor cells gives rise to distinct organ lineages,and how organ boundaries are subsequently established and maintained is less clear.

The biliary system is derived from the same region of the ventral foregut as the liver andpancreas, yet relatively little is known about early biliary development. Based on histologicalevidence, it has been suggested that the hepatic diverticulum gives rise to the liver, as well asthe IHBD, EHBD, and collecting duct and gall bladder primordium. Knockout experiments inthe mouse have identified several transcription factors, Hhex, HNF6 and HNF1β that arerequired for biliary development (Clotman et al., 2002; Coffinier et al., 2002; Hunter et al.,2007). Several of these also affect liver development, again suggesting the liver and biliarysystem share a common origin. The ventral pancreas also arises from the same region of theventral foregut as the hepatic and biliary system and loss of the Notch effector Hes1 results ingall bladder agenesis and ectopic pancreatic tissue in the common duct. This finding suggestsa developmental link between the biliary system and the pancreas (Burke et al., 2004; Fukudaet al., 2006; Sumazaki et al., 2004). This possibility is further supported by reports of congenitaldefects in humans in which linked anomalies affect both the pancreas and biliary system(Ashraf et al., 2005; Chappell et al., 2008; Galan-Gomez et al., 2007; Heij and Niessen,1987; Iguchi et al., 2005; Martinoli et al., 1980; Mehes et al., 1976; Mitchell et al., 2004).Despite all of this correlative evidence, the lineage relationship between the biliary system andeither the liver or the pancreas has not been experimentally demonstrated.

Sox17 is necessary for definitive endoderm formation in many vertebrate species includingXenopus, zebrafish and mouse. However, early embryonic lethality in Sox17-null mice hasmade studying its role during organogenesis impossible (Kanai-Azuma et al., 2002). InXenopus, Sox17 interacts with co-factors to activate transcription of target genes, such asHNF1β, that are known to be required for later development of endodermal organs (Sinner etal., 2006; Sinner et al., 2004; Zorn et al., 1999). Moreover, our data indicated that Sox17expression is maintained in the posterior foregut, suggesting to us that Sox17 might have afunction during ventral foregut organogenesis.

Spence et al. Page 2

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

We have used a combination of gene expression analysis, lineage tracing and mouse geneticsto investigate the lineage relationship between the biliary system, pancreas and liver and toidentify cell-intrinsic pathways that separate these organ lineages from a common progenitor.We have identified that: 1) The biliary system and ventral pancreas arise from a commonprogenitor that is distinct from the liver at e8.5. 2) Sox17 is a key regulator in the earlysegregation these organ lineages. 3) Loss of Sox17 results in Pdx1 expressing cells in the liverbud and ectopic pancreatic tissue in the common duct. 4) Sox17 is necessary and sufficient forspecifying a ductal fate. 5) Hes1 is required for separating the biliary and pancreatic lineagesand may act in a feedback loop with Sox17.

Together with published findings, our data supports a model where Sox17 is broadly expressedin foregut progenitor cells and is progressively downregulated in cells as they become lineagerestricted. For example, down-regulation of Sox17 in Pdx1-expressing cells is required forpancreas development. This model illustrates how one transcription factor, Sox17, might actin combination with others factors like Hex1 and Pdx1 to specify different organ lineages froma common pool of progenitor cells.

RESULTSPdx1 and Sox17 coexpression defines a common ventral foregut progenitor

Sox17 is required for endoderm formation but its role in later endoderm development is notknown. We evaluated the expression pattern of Sox17 mRNA and protein at e8.5 and foundboth in ventral foregut domain that largely overlaps with Pdx1 (Fig. 1A, Fig. S1A). This Sox17+/Pdx1+ domain is caudal to the thickening pseudostratified epithelium of the hepaticdiverticulum, which is Hhex positive at this stage (Fig. 1A). Very few cells at the boundary ofthe two domains were Hhex+/Sox17+/Pdx1+ (Fig. 1A). Over the next 24 hours of development(e9.5) the Sox17 and Pdx1 co-expression domain progressively separates into a Sox17+ biliaryprimordium (also called primordial gall bladder) and a Pdx1+ pancreatic primordia (Fig. 1,Fig. S1). Analysis of Sox17 mRNA by in situ hybridization completely coincided with Sox17protein expression (Fig. S1B,C). These expression patterns indicate a role for Sox17development of the biliary system and pancreas.

The biliary primordium, extrahepatobiliary system and ventral pancreas develop from Pdx1+ cells

Our expression data led us to hypothesize that the biliary system does is not derived from theliver primordium as previously suggested, but rather shares a common origin with the ventralpancreas and comes from the Pdx1+/Sox17+ progenitor cells in the ventral foregut. Todetermine if that the biliary system is derived from a Pdx1+ progenitor we performed a lineagetracing experiment with a Pdx1-Cre transgenic line (Wells et al., 2007) and a Rosa reportermouse. Pdx1-expressing cells were lineage labeled starting at e8.5 and analysis at e9.5 ande10.5 embryos demonstrated that the biliary primordium was LacZ-positive and thus werederived from Pdx1-expressing progenitor cells (Fig. 1C, E). Since the e10.5 biliary primordiumis negative for Pdx1 protein, these cells must be a descendent of an earlier Pdx1-cre expressingcell. Analysis of e16.5 embryos indicated that the epithelia of the duodenum, dorsal and ventralpancreas, and the extrahepatobiliary system (comprised of the gall bladder, cystic duct,common duct and extrahepatic ducts) were either derived from earlier Pdx1-expressing cells(Fig. 1F) or from de novo Pdx1 expression (Offield et al., 1996). Although theextrahepatobiliary system is derived from Pdx1-expressing cells, our analysis of Pdx1 nullembryos (Pdx1tTA/tTA) demonstrates that Pdx1 is not necessary for development of Sox17-expressing biliary primordium or subsequent development of the gall bladder, collecting duct,and common duct (Fig. 1G), which is consistent with previous reports (Jonsson et al., 1994;

Spence et al. Page 3

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

Offield et al., 1996). These data indicate that the biliary primordium and ventral pancreas areboth derived from a Pdx1+ ventral foregut progenitor.

Sox17 is necessary for development of the biliary primordiumTo investigate the function of Sox17 in the pancreatobiliary development, we deleted Sox17in the ventral foregut starting at e8.5 using two different Cre lines (Pdx1-cre and FoxA3cre)(Lee et al., 2005a; Wells et al., 2007) and two different Sox17 alleles (a conditionalSox17Flox allele and a null Sox17GFP allele) (Kim et al., 2007) (Fig. S2). Deletion of Sox17was efficient in e.9.5 embryos (FoxA3cre;Sox17Fl/Fl - LOF) and resulted in an expansion ofPdx1 expression throughout the ventral gut, which is the presumptive gall bladder region wherePdx1 is normally down regulated (Fig. 2A,B). At E10.5, control embryos had a distinct Pdx1+ ventral pancreas and Sox17+ biliary primordium, whereas the biliary primordium was absentin FoxA3cre;Sox17Fl/Fl embryos (Fig. 2C,D). Similar phenotypes were observed in E10 Pdx1-cre;Sox17Fl/GFP embryos (Fig. 2E and F). The loss of the biliary primordium in e9.5 Sox17-LOF embryos was not due to any quantitative change of cell proliferation (phosphohistone H3staining) or cell death (caspase-3 staining) (n=4 different animals) (Fig. S4). These resultsdemonstrate that Sox17 is required for development of the biliary primordium and suggest thatbiliary cells adopt a Pdx1+ pancreatic fate. In these experiments, Pdx1-cre;Sox17Fl/Fl embryoshad a less severe phenotype than Pdx1-cre;Sox17GFP/Fl because the latter embryos alreadylack one functional allele of Sox17 (Sox17GFP) (Fig. S3).

Sox17 is required for establishing distinct organ domains between the liver andpancreatobiliary system

As described above, Sox17-LOF embryos had Pdx1 expressed throughout the ventral gutendoderm (Fig. 2B, F), which is not due to loss of presumptive biliary cells through cell deathor reduced proliferation (Figure S4). This suggests that Sox17 is required to restrict Pdx1expression to the proper domain along the dorsal-ventral axis. We next investigated if Sox17is also required for establishing or maintaining boundaries between the pancreatobiliary andliver domains. In control embryos between e9.0-9.5, there are discrete boundaries between theliver bud (Prox1+) and the pancreatobiliary domain (Pdx1+ and Sox17+). Pdx1 expression isalmost never seen in the liver bud of control embryos. In contrast we observed ectopic Pdx1expressing cells throughout the liver bud of E9.5 FoxA3cre;Sox17Fl/Fl embryos (Fig. 2G,H,G′,H′,I), and in Pdx1-cre;Sox17Fl/GFP and FoxA3cre;Sox17Fl/GFP embryos (not shown).Quantitation of the number of Pdx1+ cells in the Prox1+ liver bud showed that Sox17-LOFembryos had a 10-fold higher number of ectopic Pdx1+ cells within the liver bud (7.8 +/− 3cells per liver bud section, p<0.05, n=5) relative to control embryos (0.7 +/− 0.7, n=3). Thiswas confirmed by analysis of sagittal sections of Pdx1-cre;Sox17Fl/GFP E9.0-E9.5 that clearlyshowed ectopic Pdx1+ cells in the liver bud (Fig. S5A, B). When we analyzed embryos thatwere totally null for Sox17 (Sox17GFP/GFP), the Pdx1 domain was almost completely containedwithin the Prox1 domain (Fig. S5C, D). These data suggest that Sox17 is required forestablishing and/or maintaining distinct domains between the liver and the developingpancreatobiliary system along the anterior posterior axis (Fig. 2J).

Embryos lacking Sox17 have biliary agenesis and ectopic pancreatic tissue in the ductsE10.5 Sox17-LOF embryos had agenesis of the biliary promordium, and this manifested as aloss of gall bladder and cystic duct at E16.5 (Fig. 3A,B). Moreover 50% of the E16.5 FoxA3cre;Sox17Fl/Fl embryos had visible ectopic pancreatic tissue in the common duct, consistent withthe presence of ectopic Pdx1 cells at e10 (Fig. 3A′,B′) (n=4). Hematoxylin and Eosine (H&E)and antibody staining of sections through the common duct showed pancreatic tissue buddingfrom the common duct in Sox17-LOF embryos (Fig. 3C, D). We confirmed that this was notdue to a plane of section by dissecting the common duct away from the pancreas and liver.

Spence et al. Page 4

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

Immunohistochemical analysis of the dissected common duct of E16.5 controls showed asingle layered epithelium that was positive for the duct specific lectin, DBA and for Pdx1,which are normally expressed in the duct at this stage (Fig. 3C-C‴). In contrast, the markerexpression profile of Sox17-LOF ducts was remarkably similar to that of the pancreas;branching amylase positive tissue and small islet-like clusters of insulin/glucagon positive cellsbudding off of the DBA positive duct (Fig. 3D-D‴) and reduced levels of Pdx1. Control ductshad rare insulin and glucagon positive cells as previously reported (Dutton et al., 2007) andnever express amylase. The ectopic endocrine clusters in Sox17-LOF ducts were often negativefor the duct markers HNF6 and DBA suggesting that they had lost a ductal phenotype (Fig. 3and data not shown). This suggests that removing Sox17 in the common duct is sufficient toinduce ectopic pancreas development. It is therefore not surprising that deleting Sox17 has noobvious effect on normal pancreas development (data not shown).

Sox17 misexpression suppresses pancreas developmentOur data suggest a model where Sox17 represses pancreatic fate in the bilary primoridium, andthat Sox17 must be down regulated in the ventral pancreatic cells as they separate from thebiliary lineage. We tested this possibility by maintaining Sox17 in the pancreatic lineage usinga Pdx1-driven tetracycline transactivator mouse (Pdx1tTa/+) and a tetracycline regulated Sox17transgene (Pdx1tTa/+;tetO-Sox17 = Sox17 gain-of function (GOF) (Holland et al., 2002; Parket al., 2006). In this system the Sox17 transgene is ON in the absence of doxycyline, where asadministering Dox to turns the Sox17 transgene OFF. In Sox17-GOF embryos that were neverfed doxycycline (ON), Sox17 was ectopically expressed in Pdx1-expressing cells starting ate9.5 (data not shown) and by e10.5 Sox17 was expressed throughout the Pdx1 domain. Theseembryos had a remnant of a dorsal and ventral pancreatic bud, which were fused to the guttube (Fig. 4A compared to control in Fig. 1). Formation of the biliary epithelium was relativelynormal in Sox17-GOF embryos at e10.5, indicating that ectopic Sox17 can suppress pancreasformation without affecting segregation of the biliary lineage.

Since the dorsal and ventral pancreas do not bud properly in Sox17-GOF embryos, wehypothesized that maintaining Sox17 in the pancreatic domains suppresses pancreasdevelopment. Consistent with this, expression of the pancreatic transcription factor Nkx2.2 isdramatically reduced in Sox17-GOF embryos relative to control embryos (Fig. 4B and C).Nkx2.2 is only expressed in areas where Sox17 was not ectopically expressed (Fig. 4C, boxedregion and inset). Other pancreatic markers, such as Pdx1 and Ptf1a are not affected by ectopicSox17 expression (Fig. 4A, H, I). These data suggest that Sox17 inhibits pancreas developmentdownstream of Pdx1 and Ptf1a and upstream of Nkx2.2. It also suggests that Sox17 does notdirectly down regulate Pdx1 during separation of the pancreatic and biliary lineages.

We examined expression of Hnf6 and Hhex, which are also expressed in this region of the gut.Hhex is normally restricted to the ventral gut structures at E10.5, including the ventral pancreas,biliary and liver primordia (Bort et al., 2004; Hunter et al., 2007) but is not normally expressedin the midgut or dorsal pancreas. However, in Sox17-GOF embryos Hhex expression wasdorsally expanded into the gut and even expressed in the presumptive dorsal pancreas (Fig.4F,G). The normal expression of Hnf6 throughout the biliary primordium, dorsal and ventralpancreas and midgut is not changed by Sox17 misexpression at E10.5 (Fig. 4D,E). As expected,liver bud development was not altered in Sox17-GOF embryos since the Pdx1tTa is not activein the liver (data not shown). Taken together these results suggest that Sox17 suppressespancreatic fate and that down-regulating Sox17 from the Pdx1 domain is crucial for normalpancreas development.

Spence et al. Page 5

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

Sox17 misexpression causes organ dysgenesis throughout the Pdx1 domainSox17 misexpression suppressed early pancreatic development and mispatterned the gut, butit was not clear what these cells had become in response to Sox17 expression. Since Sox17 isrequired for biliary specification, one possibility is that Sox17 misexpression directed some ofthese cells into a biliary and ductal fate. In order to test this we analyzed the fate of Sox17expressing cells at e16.5. Compared to control embryos, Sox17-GOF embryos had a large massat the pyloric junction (Fig. 5A-D) and had a dramatic decrease in the amount of pancreatictissue (Fig. 5B, Supplemental Fig. 4). In lineage traced embryos (Pdx1-tTa;tetO-cre;tetO-Sox17;R26R) we found that the entire ectopic structure was derived from Sox17-overexpressing cells (Fig. S6).

Histological analysis of Sox17-GOF embryos at e16.5 revealed many ectopic duct-likestructures that expressed the duct marker HNF6 (Fig. 5E, F). The stomach epithelium andmesenchyme in the GOF embryos both appeared hyperplasic (Fig. 5D). While some ectopicductal tissue was negative for the gut epithelial marker HNF4α, other regions were HNF6/HNF4α double positive, suggesting that these cells had the properties of both gut and ductalepithelium (Fig. 5F). The ectopic tissue mass contained regions of duodenal-like villi that wereinterspersed with a hyperplasic ductal-like epithelium. The gut epithelial marker villin(Braunstein et al., 2002) (Fig. 5G) was absent from large regions of the protuberance in Sox17-GOF embryos (Fig. 5H). These data suggest that persistent Sox17 expression suppressespancreatic development and is sufficient to induce ectopic ductal tissue in the stomach andduodenum. Since there is no marker that can distinguish one type of ductal epithelia fromanother, it is impossible to determine if the ectopic ductal tissue present in the Sox17-GOFembryos is biliary.

The role of Sox17 in directing a biliary versus pancreatic cell fate choice is temporallyrestricted to e8.5-e10.5

Since the tetO-Sox17 transgene was constitutively misexpressed between e8.5 and e16.5 ofdevelopment, it was not clear when during development Sox17 misexpression was causingthese phenotypes. To investigate this, we gave a pulse of Sox17 expression for different lengthsof time between e8.5 to e12.5 and then analyzed the embryos at e16.5. We found thatmisexpression of Sox17 between e8.5-10.5 gave the same phenotypes as maintained expressionfrom e8.5-e16.5: loss of pancreatic tissue and the formation of a tissue mass containing ectopicductal tissues and disorganized stomach and duodenal epithelium (Fig. 6A, D). In the converseexperiment where the Pdx1tTa/+; tetO-Sox17 transgene was induced after e12.5, pancreaticdevelopment was grossly normal and no ectopic mass was detected at the pyloric-duodenaljunction (data not shown). We based the timing of tetO-Sox17 on previous experiments thatdemonstrated that the Pdx1 tet-transactivator initiates transgene expression at e8.5 and is downregulated within one day of doxycycline treatment (Hale et al., 2005).

Sox17 misexpression is sufficient to induce a ductal cell fate in the pancreas at the expenseof other lineages

Given the appearance of ectopic ductal tissue in the duodenum the Sox17-GOF embryos wehypothesized that Sox17 might have the general property of promoting a ductal fate. To testthis we misexpressed Sox17 in the pancreas of animals starting at E12.5, where it is normallynot expressed (Sox17 ON in Pdx1-cells at E12.5) and examined the pancreas at E16.5 and at6 weeks (Fig. 6G-J). At E16.5, the Sox17-GOF pancreas was the same size as in controlanimals, however histological analysis showed a dramatic increase in DBA positive ductalcells relative to control animals (Fig. 6G, H). This increase in DBA positive ductal tissueappeared to come at the expense of endocrine cells, which were dramatically reduced in theseanimals (data not shown). Furthermore, H&E staining showed that the pancreas of 6-week oldSox17-GOF animals had a massive expansion of ductal tissue, whereas acinar tissue was

Spence et al. Page 6

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

reduced and mature endocrine cells were nearly absent (Fig. 6I, J and data not shown). Theseresults suggest that Sox17 misexpression in the pancreas is sufficient to promote a pancreaticductal cell fate at the expense of the other lineages.

Together with the loss-of-function data, we conclude that Sox17 is required between e8.5 ande10.5 to properly segregate the foregut progenitors into the biliary and pancreatic lineages, andthat sustained Sox17 expression in the Pdx1+ cells in this period is sufficient to suppresspancreas and induce ectopic biliary fate.

Hes1 regulates the segregation of Sox17/Pdx1 lineages from common foregut progenitorsPrevious studies have implicated the Notch, FGF10, and hedgehog signaling pathways in thedevelopment of the ventral pancreas and biliary tree. We used existing mouse mutant lines todetermine if any of these pathways were involved in establishing the Sox17/Pdx1 pancreatic-biliary progenitor domain. Embryos lacking either FGF10 (FGF10 null) or the hedgehog co-receptor smoothened (Pdx1-cre;smoothenedFl/Fl) formed a normal Sox17+/Pdx1+ progenitordomain that resolved into biliary and pancreatic primordial that were indistinguishable fromcontrol embryos at E10.5 (Fig. S7). As previously reported, FGF10 null embryos at later stageshad pancreatic and biliary defects that occur after specification and segregation of the ventralpancreas and gall bladder primordium (data not shown).

In contrast, our analysis of embryos lacking Hairy Enhancer of Split-1 (Hes1−/−), atranscriptional effector of notch signaling, demonstrated that Hes1 is required for formation ofthe ventral pancreatic and biliary bud. In Hes1−/− embryos at e9.5, the Sox17 expressiondomain was expanded dorsally in a scattered fashion, and we even observe Sox17+ cells in thedorsal pancreas (Fig. 7A,B and inset. NOTE: Fig. 7 is presented with separated channel colorsin Fig. S8). This suggests that Hes1 acts to restrict Sox17+ cells to the ventral gut. At e10.5Sox17 and Pdx1 expression was nearly absent in ventral endoderm of Hes1−/− embryos, andthe ventral pancreas and biliary primordium did not develop into distinct structures (Fig. 7C,D). Failure to separate these domains is catastrophic and results in biliary agenesis, hypoplasiaof the EHBD and replacement of the common duct with pancreatic tissue as previously reported(Fukuda et al., 2006; Sumazaki et al., 2004). We have not determined if Hes1 is acting as aNotch effector in this context, as it can also have Notch-independent effects.

In addition, our analysis of Sox17-LOF and Sox17-GOF embryos suggests a functionalconnection between Sox17 and Hes1 in controlling biliary development. First, the Sox17-LOFphenotype is strikingly similar to Hes1−/− animals, with gall bladder agenesis and ectopicpancreatic tissue in the common duct (Fig. 2,3) (Fukuda et al., 2006;Sumazaki et al., 2004).Second, misexpression of Sox17 in Pdx1-positive cells in the dorsal and ventral pancreascoincides with an increase in HES1 protein levels at e9.5 (Fig. 7E, F) and e10.5 (Fig. S8).Third, HES1 protein expression is reduced in Sox17-LOF animals (Fig. 7G, H) suggesting thatSox17 appears to positively effect Hes1 expression but is not absolutely required for itsexpression. Lastly, Sox17+/Pdx1+ progenitor cells express higher levels of HES1 protein thanSox17−/Pdx1+ cells (Fig. 7E and S8E, compare dorsal Sox17−/Pdx1+ vs. ventral Sox17+/Pdx1+). Taken together our results suggest a model where between E8.5 and 9.5, Sox17 andHes1 may be involved in a regulatory feedback loop where high levels of Sox17 in Pdx1positive cells act to promote Hes1 expression, which then in turn progressively restricts Sox17-expressing, Pdx1 negative cells to the ventral gut (Fig. 7I). Early cell segregation defects inthe Hes1 mutant embryo are associated with a reduction of both Sox17 and Pdx1 expressingcells at E10.5 and disruption of organ development.

While our results clearly show that Hes1 is required for proper segregation of Sox17/Pdx1lineages from common foregut progenitors, further studies are needed to elucidate the

Spence et al. Page 7

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

molecular mechanism by which Hes1 and Sox17 work to restrict biliary progenitors to theventral-most domain of the pancreatic/biliary bud.

DISCUSSIONA Sox17-dependent mechanism for specifying organ cell fate and establishing boundariesis required for normal pancreas, biliary and liver development

The liver, ventral pancreas and biliary system are all derived from several hundred endodermcells found in the caudal region of the ventral foregut. We presented data to demonstrate arequirement for Sox17 in lineage choice between a pancreatic and biliary cell fate. We proposea model (Fig. S10) where Sox17 is broadly expressed in the presumptive foregut and is thenprogressively down regulated in the different organ domains as they are specified. For example,at E8.5 Sox17 is down regulated in the presumptive Hhex1+ domain as hepatic cells arespecified, then it is down regulated in the Pdx1+ cells as ventral pancreatic cells are specified.Finally, Sox17 expression is maintained in a subset of biliary progenitors that give rise to thegall bladder, cystic duct, common duct and extrahepatic bile ducts. Our data further suggeststhat the Sox17 is required either to establish or maintain distinct boundaries between the liver,biliary and pancreatic domain since the loss of Sox17 results in ectopic Pdx1 cells in the liverbud and biliary system. Furthermore, we have shown that the Sox17-dependant segregation ofpancreatic and biliary domains requires Hes1 (discussed below and Fig. S10). The factors thatregulate the dynamic expression of Sox17 during foregut organogenesis still need to beinvestigated.

Feedback between Sox17 and Hes1 during biliary and pancreas developmentThe Sox17 loss-of-function phenotype is strikingly similar to Hes1−/− animals, with gallbladder agenesis and ectopic pancreatic tissue in the common duct (Fukuda et al., 2006;Sumazaki et al., 2004), suggesting that these two molecules act in the same pathway. WhileSox17 is not required for Hes1 expression our data indicates that Sox17 is able to regulate Hes1levels in Pdx1-expressing endoderm; Hes1 protein is reduced in Sox17-LOF animals and iselevated in Pdx1+ cells that overexpress Sox17 in the dorsal pancreas. Importantly we observehigher Hes1 protein levels in the normal context of ventral cells that co-express Pdx1 andSox17, suggesting that progenitors are defined as Pdx1+/Sox17+/high Hes1.

Interestingly, our data suggest a negative feedback loop exists between Hes1 and Sox17 sinceSox17 cells expand dorsally in Hes1−/− embryos and Sox17+ cells are even found in the dorsalpancreas. The absolute levels of Sox17 do not change, suggesting that Hes1 does not directlyrepress Sox17 expression, rather, Hes1 restricts Sox17 cells to the ventral part of the bud in anindirect manner. While more work is needed to work out the exact details of how Sox17 andHes1 cooperate to regulate lineage segregation, it is interesting to speculate that Pdx1 andSox17 may be cooperating between e8.5 and e9.5 to drive high Hes1 levels, and that Hes1feeds back to limit Sox17-expressing cells to the ventral gut (Fig. S10). Our data shows thatfailure to ventrally restrict Sox17+ cells in Hes1−/− embryos at e9.5 corresponds with loss ofthe biliary primordium at e10.5. It is possible that some Sox17 cells at e9.5 are converted to apancreatic fate, consistent with the formation of ectopic pancreatic tissue in Hes1−/− embryos(Fukuda et al., 2006;Sumazaki et al., 2004). Alternatively, early mislocaliztion of Sox17+ cellsmight trigger their apoposis, resulting in loss of biliary structures by e10.5. This possibilityremains to be determined.

Our data explain why mutations in either Sox17 or Hes1 cause similar phenotypes, and suggestthat the reported phenotypes in Hes1−/− embryos are due in part to Sox17-dependent defectsand visa-versa. Since Sox17 cells are not properly localized Hes1−/− embryos, and Hes1expression is reduced in Sox17-LOF embryos, mutations in either would feed back and cause

Spence et al. Page 8

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

failure in pancreas and biliary lineages to properly segregate, loss of biliary tissue, and de-repression of pro-pancreatic factors. Ectopic pancreas formation in Hes1−/− embryos wasattributed to suppressing pancreatic transcription factors Ptf1a/p48 and Ngn3 in ductal epitheliathat already expressed endogenous Pdx1 (Esni et al., 2004; Fukuda et al., 2006; Ghosh andLeach, 2006; Jensen et al., 2000; Sumazaki et al., 2004). It is not clear if ectopic pancreatictissue in Sox17-LOF embryos is due to early mis-segregation of biliary and pancreatic lineagesor a reduction in Hes1 protein expression in the duct at later stages. Pancreatic markers havebeen observed at low levels in biliary system (Dutton et al., 2007), suggesting that thisepithelium has latent pancreatic potential that could be enhanced by removal of biliarydeterminants like Sox17 or Hes1.

Sox17 is upstream in a cascade of transcription factors that regulates biliary treedevelopment

The transcription factors Hhex, HNF6 (Onecut One), HNF1® and HNF4⟨ play roles in differentaspects of biliary tree development (Clotman et al., 2002; Hunter et al., 2007; Matthews et al.,2004). Since our studies demonstrate that Sox17 is also involved in early biliary development,it is possible that Sox17, Hhex and HNF6 form a transcriptional network that regulatesdevelopment of the biliary system. Consistent with this, misexpression of Sox17 throughoutthe dorsal Pdx1 domain is sufficient to induce ectopic expression of Hhex in the duodenumand dorsal pancreas at E10.5. Moreover, Sox17 misexpression is sufficient to induce the biliary/ductal molecular program resulting in HNF6 expression in ectopic ductal structures throughoutthe Pdx1 expression domain. These data suggest that Sox17 might act a master regulator of thebiliary/ductal lineage upstream of Hhex and is sufficient for diverting other cell types into thebiliary lineage. We have also shown that Sox17 overexpression in the pancreas at E12.5, whenit is not normally expressed, is sufficient to promote a ductal fate, apparently at the expense ofendocrine cells. This supports the idea that Sox17 acts at the top of a hierarchy and can activatea transcriptional program resulting in a ductal fate.

An alternative model for biliary developmentOur lineage tracing and gene expression data indicates that the biliary system shares a commonorigin with ventral pancreas and not the liver as previously thought (Figure S10) (Clotman etal., 2002; Hunter et al., 2007; Shiojiri, 1997). The fact that Sox17 and Hes1 LOF affected thebiliary and pancreatic lineages also supports this conclusion. Lastly, congenital defects havebeen reported in humans that have linked anomalies in both the pancreas and biliary system.It is likely that a common progenitor for liver, biliary system and pancreas exists at earlierstages of development, when the anterior definitive endoderm is forming the foregut, and thatthe first of these lineages to separate is the liver. This possibility is supported by studies inZebrafish, where single lineage traced cells gave rise to committed liver cells and Pdx1-positivecells. Those Pdx1 positive cells, our data would suggest, are the pancreatobiliary progenitors.

These data describe a Sox17-based model for extrahepatic biliary development from a Pdx1progenitor. It is important to point out that the intrahepatic bile ducts (IHBD) were not lineagelabeled using Pdx1-cre and were not affected in Sox17-LOF or Sox17-GOF studies (data notshown). Therefore, development of the entire biliary tree might be dependant on cells derivedfrom different populations of progenitor cells. The EHBDs, common duct, cystic duct and gallbladder are derived from a Pdx1+ progenitor cell, whereas the IHBDs are derived from a hepaticprogenitor cell (Fig. S10). This model could provide insight into the causes of human congenitalabnormalities affecting both pancreas and biliary tree. Moreover, a better understanding ofhow endoderm organ lineages are initially segregated will inform efforts at directeddifferentiation of human ES cells into endoderm derivatives (Spence and Wells, 2007).

Spence et al. Page 9

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

EXPERIMENTAL PROCEDURESImmunohistochemistry

Tissues were either fixed overnight and embedded in paraffin, or fixed for 1 hour, equilibratedin 30% sucrose/1xPBS, and frozen in OCT. Sections were cut 6-10 micrometers thick. Paraffinsections were deparaffinized, dehydrated and we performed antigen retrieval by steamingslides in sodium citrate buffer for 30 minutes. Sections were blocked in the appropriate serum(5% serum in 1x PBS + 0.5% triton-X) for 30 minutes. Primary antibodies were diluted inblocking buffer and incubated on tissue sections overnight at 4 degrees Celsius. Slides werewashed and incubated in secondary antibody in blocking buffer for 2 hours at roomtemperature. For a list of antibodies used and dilutions, see supplemental experimentalprocedures. Slides were washed and mounted using Fluormount-G.

LacZ staining and histology analysisBeta-galactosidase activity was detected in fixed whole tissue using the Histomark X-galsubstrate system (Kireguard and Perry Laboratories, MD). For hematoxylin and eosin staining,6 μm paraffin sections were dewaxed in xylene, rehydrated, and stained.

MiceAll mice used in these studies were housed at the Cincinnati Children's Hospital ResearchFoundation mouse facility, and were maintained according to institutional protocols. Pdx1-cre, Pdx1-tTa, FoxA3cre, Sox17-GFP, FGF10, SmoothenedFl and Hes1 mice have all beenpreviously described (Bellusci et al., 1997; Holland et al., 2002; Ishibashi et al., 1995; Kim etal., 2007; Lee et al., 2005b; Wells et al., 2007; Zhang et al., 2001). The generation of theSox17Fl mice is described in the Supplemental Materials and Methods.

Supplementary MaterialRefer to Web version on PubMed Central for supplementary material.

ACKNOWLEDGEMENTSWe thank Vladimir Kalinichenko, Chris Wylie, Ben Stanger, Gail Deutsch and Aaron Zorn and the Wells and Zornlabs for input on the work. We also thank Sean Morrison (University of Michigan) and Raymond MacDonald(University of Texas Southwestern) for the Sox17GFP and Pdx1tTA mice. Nadean Brown (Cincinnati Children'sHospital Medical Center) and Clifford Bogue (Yale University) kindly provided the Hes1 and Hhex antibodies,respectively. This work was supported by a career development award from the Juvenile Diabetes Research Foundation(JDRF-2-2003-530) and a grant from the NIH (R01GM072915). JRS was supported by postdoctoral fellowship fromthe JDRF and an NIH training grant in Developmental and Perinatal Endocrinology (T32 HD07463).

ReferencesAshraf A, Abdullatif H, Hardin W, Moates JM. Unusual case of neonatal diabetes mellitus due to

congenital pancreas agenesis. Pediatric Diabetes 2005;6:239–243. [PubMed: 16390394]Bhushan A, Itoh N, Kato S, Thiery JP, Czernichow P, Bellusci S, Scharfmann R. Fgf10 is essential for

maintaining the proliferative capacity of epithelial progenitor cells during early pancreaticorganogenesis. Development 2001;128:5109–5117. [PubMed: 11748146]

Bort R, Martinez-Barbera JP, Beddington RS, Zaret KS. Hex homeobox gene-dependent tissuepositioning is required for organogenesis of the ventral pancreas. Development 2004;131:797–806.[PubMed: 14736744]

Bort R, Signore M, Tremblay K, Martinez Barbera JP, Zaret KS. Hex homeobox gene controls thetransition of the endoderm to a pseudostratified, cell emergent epithelium for liver bud development.Developmental Biology 2006;290:44–56. [PubMed: 16364283]

Spence et al. Page 10

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

Braunstein EM, Qiao XT, Madison B, Pinson K, Dunbar L, Gumucio DL. Villin: A marker fordevelopment of the epithelial pyloric border. Dev Dyn 2002;224:90–102. [PubMed: 11984877]

Burke ZD, Shen CN, Tosh D. Bile ducts as a source of pancreatic beta cells. Bioessays 2004;26:932–937. [PubMed: 15351963]

Chappell L, Gorman S, Campbell F, Ellard S, Rice G, Dobbie A, Crow Y. A further example of adistinctive autosomal recessive syndrome comprising neonatal diabetes mellitus, intestinal atresiasand gall bladder agenesis. Am J Med Genet A 2008;146A:1713–1717. [PubMed: 18512226]

Chung WS, Shin CH, Stainier DY. Bmp2 signaling regulates the hepatic versus pancreatic fate decision.Dev Cell 2008;15:738–748. [PubMed: 19000838]

Clotman F, Lannoy VJ, Reber M, Cereghini S, Cassiman D, Jacquemin P, Roskams T, Rousseau GG,Lemaigre FP. The onecut transcription factor HNF6 is required for normal development of the biliarytract. Development 2002;129:1819–1828. [PubMed: 11934848]

Coffinier C, Gresh L, Fiette L, Tronche F, Schutz G, Babinet C, Pontoglio M, Yaniv M, Barra J. Bilesystem morphogenesis defects and liver dysfunction upon targeted deletion of HNF1beta.Development 2002;129:1829–1838. [PubMed: 11934849]

Deutsch G, Jung J, Zheng M, Lora J, Zaret KS. A bipotential precursor population for pancreas and liverwithin the embryonic endoderm. Development 2001;128:871–881. [PubMed: 11222142]

Dong PD, Munson CA, Norton W, Crosnier C, Pan X, Gong Z, Neumann CJ, Stainier DY. Fgf10 regulateshepatopancreatic ductal system patterning and differentiation. Nature Genetics 2007;39:397–402.[PubMed: 17259985]

Dutton JR, Chillingworth NL, Eberhard D, Brannon CR, Hornsey MA, Tosh D, Slack JM. Beta cellsoccur naturally in extrahepatic bile ducts of mice. J Cell Sci 2007;120:239–245. [PubMed: 17179205]

Esni F, Ghosh B, Biankin AV, Lin JW, Albert MA, Yu X, MacDonald RJ, Civin CI, Real FX, Pack MA,et al. Notch inhibits Ptf1 function and acinar cell differentiation in developing mouse and zebrafishpancreas. Development 2004;131:4213–4224. [PubMed: 15280211]

Fukuda A, Kawaguchi Y, Furuyama K, Kodama S, Horiguchi M, Kuhara T, Koizumi M, Boyer DF,Fujimoto K, Doi R, et al. Ectopic pancreas formation in Hes1 - knockout mice reveals plasticity ofendodermal progenitors of the gut, bile duct, and pancreas. J Clin Invest 2006;116:1484–1493.[PubMed: 16710472]

Fukuda S, Mizuno T. Hepatic parenchyma, biliary ducts and gall bladder forming potency in the hepaticprimordium in the quail embryo. Anatomy & Embryology 1978;155:15–21. [PubMed: 727519]

Galan-Gomez E, Sanchez EB, Arias-Castro S, Cardesa-Garcia JJ. Intrauterine growth retardation,duodenal and extrahepatic biliary atresia, hypoplastic pancreas and other intestinal anomalies: furtherevidence of the Martinez-Frias syndrome. Eur J Med Genet 2007;50:144–148. [PubMed: 17321227]

Ghosh B, Leach SD. Interactions between hairy/enhancer of split-related proteins and the pancreatictranscription factor Ptf1-p48 modulate function of the PTF1 transcriptional complex. Biochem J2006;393:679–685. [PubMed: 16201968]

Gualdi R, Bossard P, Zheng M, Hamada Y, Coleman JR, Zaret KS. Hepatic specification of the gutendoderm in vitro: cell signaling and transcriptional control. Genes Dev 1996;10:1670–1682.[PubMed: 8682297]

Hale MA, Kagami H, Shi L, Holland AM, Elsasser HP, Hammer RE, MacDonald RJ. The homeodomainprotein PDX1 is required at mid-pancreatic development for the formation of the exocrine pancreas.Dev Biol 2005;286:225–237. [PubMed: 16126192]

Hebrok M, Kim SK, Jacques B, McMahon AP, Melton DA. Regulation of pancreas development byhedgehog signaling. Development 2000;127:4905–4913. [PubMed: 11044404]

Heij HA, Niessen GJ. Annular pancreas associated with congenital absence of the gallbladder. Journalof Pediatric Surgery 1987;22:1033. [PubMed: 3430309]

Holland AM, Hale MA, Kagami H, Hammer RE, MacDonald RJ. Experimental control of pancreaticdevelopment and maintenance. Proceedings of the National Academy of Sciences of the United Statesof America 2002;99:12236–12241. [PubMed: 12221286]

Hunter MP, Wilson CM, Jiang X, Cong R, Vasavada H, Kaestner KH, Bogue CW. The homeobox geneHhex is essential for proper hepatoblast differentiation and bile duct morphogenesis. Dev Biol2007;308:355–367. [PubMed: 17580084]

Spence et al. Page 11

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

Iguchi H, Ikeda Y, Okamura M, Tanaka T, Urashima Y, Ohguchi H, Takayasu S, Kojima N, Iwasaki S,Ohashi R, et al. SOX6 attenuates glucose-stimulated insulin secretion by repressing PDX1transcriptional activity and is down-regulated in hyperinsulinemic obese mice. J Biol Chem2005;280:37669–37680. [PubMed: 16148004]

Jacquemin P, Yoshitomi H, Kashima Y, Rousseau GG, Lemaigre FP, Zaret KS. An endothelial-mesenchymal relay pathway regulates early phases of pancreas development. DevelopmentalBiology 2006;290:189–199. [PubMed: 16386727]

Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, Ishibashi M, Kageyama R, Guillemot F, Serup P,Madsen OD. Control of endodermal endocrine development by Hes-1. Nat Genet 2000;24:36–44.[PubMed: 10615124]

Jonsson J, Carlsson L, Edlund T, Edlund H. Insulin-promoter-factor 1 is required for pancreasdevelopment in mice. Nature 1994;371:606–609. [PubMed: 7935793]

Kanai-Azuma M, Kanai Y, Gad JM, Tajima Y, Taya C, Kurohmaru M, Sanai Y, Yonekawa H, YazakiK, Tam PP, et al. Depletion of definitive gut endoderm in Sox17-null mutant mice. Development2002;129:2367–2379. [PubMed: 11973269]

Kawaguchi Y, Cooper B, Gannon M, Ray M, MacDonald RJ, Wright CV. The role of the transcriptionalregulator Ptf1a in converting intestinal to pancreatic progenitors. Nat Genet 2002;32:128–134.[PubMed: 12185368]

Kim I, Saunders TL, Morrison SJ. Sox17 dependence distinguishes the transcriptional regulation of fetalfrom adult hematopoietic stem cells. Cell 2007;130:470–483. [PubMed: 17655922]

Kim SK, Melton DA. Pancreas development is promoted by cyclopamine, a hedgehog signaling inhibitor.Proc Natl Acad Sci U S A 1998;95:13036–13041. [PubMed: 9789036]

Krapp A, Knofler M, Ledermann B, K B.r. Berney C, Zoerkler N, Hagenb chle O, Wellauer PK. ThebHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatialorganization of the endocrine pancreas [In Process Citation]. Genes Dev 1998;12:3752–3763.[PubMed: 9851981]

Le Douarin N. [Synthesis of glycogen in hepatocytes undergoing differentiation: role of homologous andheterologous mesenchyma]. Dev Biol 1968;17:101–114. [PubMed: 5642020]

Le Douarin NM. On the origin of pancreatic endocrine cells. Cell 1988;53:169–171. [PubMed: 3282672]Lee CS, Friedman JR, Fulmer JT, Kaestner KH. The initiation of liver development is dependent on Foxa

transcription factors. Nature 2005;445:944–947. [PubMed: 15959514]Litingtung Y, Lei L, Westphal H, Chiang C. Sonic hedgehog is essential to foregut development. Nat

Genet 1998;20:58–61. [PubMed: 9731532]Manfroid I, Delporte F, Baudhuin A, Motte P, Neumann CJ, Voz ML, Martial JA, Peers B. Reciprocal

endoderm-mesoderm interactions mediated by fgf24 and fgf10 govern pancreas development.Development 2007;134:4011–4021. [PubMed: 17942484]

Matthews RP, Lorent K, Russo P, Pack M. The zebrafish onecut gene hnf-6 functions in an evolutionarilyconserved genetic pathway that regulates vertebrate biliary development. Dev Biol 2004;274:245–259. [PubMed: 15385156]

Mehes K, Vamos K, Goda M. Agenesis of pancreas and gall-bladder in an infant of incest. ActaPaediatrica Academiae Scientiarum Hungaricae 1976;17:175–176. [PubMed: 1027315]

Mitchell J, Punthakee Z, Lo B, Bernard C, Chong K, Newman C, Cartier L, Desilets V, Cutz E, HansenIL, et al. Neonatal diabetes, with hypoplastic pancreas, intestinal atresia and gall bladder hypoplasia:search for the aetiology of a new autosomal recessive syndrome. Diabetologia 2004;47:2160–2167.[PubMed: 15592663]

Offield MF, Jetton TL, Labosky PA, Ray M, Stein RW, Magnuson MA, Hogan BL, Wright CV. PDX-1is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development1996;122:983–995. [PubMed: 8631275]

Park KS, Wells JM, Zorn AM, Wert SE, Whitsett JA. Sox17 influences the differentiation of respiratoryepithelial cells. Developmental Biology 2006;294:192–202. [PubMed: 16574095]

Rosenquist GC. The location of the pregut endoderm in the chick embryo at the primitive streak stage asdetermined by radioautographic mapping. Dev Biol 1971;26:323–335. [PubMed: 5168311]

Spence et al. Page 12

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

Serls AE, Doherty S, Parvatiyar P, Wells JM, Deutsch GH. Different thresholds of fibroblast growthfactors pattern the ventral foregut into liver and lung. Development 2005:35–47. [PubMed:15576401]

Shin D, Shin CH, Tucker J, Ober EA, Rentzsch F, Poss KD, Hammerschmidt M, Mullins MC, StainierDY. Bmp and Fgf signaling are essential for liver specification in zebrafish. Development2007;134:2041–2050. [PubMed: 17507405]

Shiojiri N. Development and differentiation of bile ducts in the mammalian liver. Microsc Res Tech1997;39:328–335. [PubMed: 9407543]

Sinner D, Kirilenko P, Rankin S, Wei E, Howard L, Kofron M, Heasman J, Woodland HR, Zorn AM.Global analysis of the transcriptional network controlling Xenopus endoderm formation.Development 2006;133:1955–1966. [PubMed: 16651540]

Sinner D, Rankin S, Lee M, Zorn A. Sox17 and beta-catenin cooperate to regulate the transcription ofendodermal genes. Development 2004;131:3069–3080. [PubMed: 15163629]

Spence JR, Wells JM. Translational embryology: Using embryonic principles to generate pancreaticendocrine cells from embryonic stem cells. Developmental Dynamics 2007;236:3218–3227.[PubMed: 17973329]

Sumazaki R, Shiojiri N, Isoyama S, Masu M, Keino-Masu K, Osawa M, Nakauchi H, Kageyama R,Matsui A. Conversion of biliary system to pancreatic tissue in Hes1-deficient mice. Nat Genet2004;36:83–87. [PubMed: 14702043]

Tremblay KD, Zaret KS. Distinct populations of endoderm cells converge to generate the embryonicliver bud and ventral foregut tissues. Developmental Biology 2005;280:87–99. [PubMed: 15766750]

Wells JM, Esni F, Boivin GP, Aronow BJ, Stuart W, Combs C, Sklenka A, Leach SD, Lowy AM. Wnt/beta-catenin signaling is required for development of the exocrine pancreas. BMC DevelopmentalBiology 2007;7:4. [PubMed: 17222338]

Zorn AM, Barish GD, Williams BO, Lavender P, Klymkowsky MW, Varmus HE. Regulation of Wntsignaling by Sox proteins: XSox17 alpha/beta and XSox3 physically interact with beta-catenin. MolCell 1999;4:487–498. [PubMed: 10549281]

Spence et al. Page 13

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

Figure 1. Sox17 and Pdx1 are coexpressed in ventral foregut progenitor cellsA. Sagittal section of an E8.5 embryo showing that Pdx1 (red) and Sox17 (blue) are co-expressed in the ventral foregut in a domain adjacent to the Hhex (green) positive liverprimordium. Only a few cells at the boundary between the Pdx1/Sox17 and Hhex domains co-express Pdx1, Sox17 and Hhex (arrows). Right panels show individual channels. The cardiacmesoderm is indicated with dashed lines. The boxed region in the schematic on the righthighlights the relative region of the staining and the orientation of the embryo (A – anterior, P– posterior).

Spence et al. Page 14

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

B. Transverse section of an E9.5 showing that the Sox17/Pdx1 co-expression domain has begunto separate into a ventrally located Sox17-high/Pdx1-low domain a Pdx1-high/Sox17-lowdomain. Sox17 protein (blue) and Pdx1 protein (red) are shown in separate color channels.C. At E9.5 both the dorsal and ventral foregut are lineage labeled using Pdx1-cre and Rosa26-LacZ (R26R) mice.D. At E10.5 the Pdx1 and Sox17 expression domains resolve into a Pdx1-expressing (red)ventral pancreas (vp) and a Sox17-expressing (green) biliary primordium/gall bladder (pgb).Pdx1 is also expressed in the dorsal pancreas (dp) and midgut (mg).E. The E10.5 biliary primordium/gall bladder comes from a Pdx1-expressing progenitor cell.The gall bladder primordium is negative for the Pdx1 protein but is lineage labeled by Pdx1-cre in Rosa26-LacZ mice.F. Pdx1-cre lineage tracing shows that at E16.5 the duodenum (d), ventral pancreas (vp) dorsalpancreas (dp), gall bladder (gb), collecting duct, common duct and cystic duct are alldescendants of a Pdx1 positive precursor. Inset (top) shows a section through the gall bladderlineage labeled with LacZ. Inset (bottom) shows the common duct and cystic ducts lineagelabeled with LacZ.G. Pdx1 is not required for normal biliary development. At E16.5, Pdx1 null mice(PdxttTa/tTa) lack a pancreas, but have a gall bladder and cystic duct.Scale bars in A, B and D are 20um.

Spence et al. Page 15

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

Figure 2. Sox17 is required for development of the biliary primordium and for establishing and/or maintaining organ boundaries between the pancreas and liverA and B. Pdx1 (red) and Sox17 (blue) expression in the ventral foregut of (A) E9.5 controlFoxA3cre;Sox17Fl/+ embryos or (B) FoxA3cre;Sox17Fl/Fl embryos, which show an almostcomplete loss of Sox17 (blue) expression and a ventral expansion of Pdx1 expression. Dashedlines outline the ventral region of the gut tube where the ventral pancreas (red) and biliarysystem (blue) are developing.C and D. Pdx1 (green) and Sox17 (red) expression in E10.5 control (C) andFoxA3cre;Sox17Fl/Fl (D) embryos. FoxA3cre;Sox17Fl/Fl embryos entirely lack a biliary/gallbladder primordium. Pdx1 staining (green) marks the dorsal and ventral pancreas in bothcontrol and FoxA3cre;Sox17Fl/Fl embryos.E and F. In E10.0 control embryos (E), the ventral Pdx1/Sox17 domains have begun to resolveinto a distinct Pdx1 expressing ventral pancreas (red) and a Sox17 expressing biliaryprimordium (blue). In Pdx1-cre;Sox17Fl/GFP embryos (F) the Sox17-expression domain isreplaced by Pdx1-positive epithelium and there is no evidence of a biliary bud. Dashed linesoutline the ventral region of the gut tube where the ventral pancreas (red) and biliary system(blue) are developing.G and H. Pdx1 (red), Sox17 (blue) and Prox1 (green) expression in E9.5control (G) or Foxa3cre;Sox17Fl/Fl (H) embryos. At E9.5 Pdx1 (red) positive cells are almostnever seen in the ventral most part of the liver diverticulum (G and G′). However, inFoxA3cre;Sox17Fl/Fl embryos(H and H′) there were many Pdx1 positive cells scatteredthroughout the liver diverticulum. I. Quantitation of ectopic Pdx1+ cells in the liverdiverticulum (Sox17-LOF include FoxA3cre;Sox17Fl/Fl and FoxA3cre;Sox17Fl/GFP embryos).There were 10-fold more Pdx1+ cells in the Sox17-LOF liver bud than in controls (control 0.7+/− 0.7 cells/liver bud (n=3) vs. Sox17-LOF 7.8 +/− 3 cells/liver bud (n=5), p<0.05). Errorbars denote standard error.J. Schematic of Sox17-LOF results. At E9.5, deletion of Sox17 results in loss of biliary cellsand an expansion of Pdx1+ cells into the liver bud. By E10.5 Sox17-LOF embryos completely

Spence et al. Page 16

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

lacked the biliary primordium. The schematic only shows the ventral region of the gut and notthe dorsal pancreas. Lines denote the plane of section shown in A-H.

Spence et al. Page 17

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

Figure 3. Loss of Sox17 leads to gall bladder agenesis and ectopic pancreas development at e16.5A and B. As compared to control embryos at e16.5 (A), FoxA3cre;Sox17Fl/Fl embryos (B)completely lack a gall bladder (gb). However, the liver (L), intestine (i), pancreas (p) andstomach (s) appear grossly normal. In (B) the arrow points to a blood vessel (bv) in betweenthe lobes of the liver. A′ and B′ shows a different view of A and B. In this view, the commonduct is visible (dashed lines). The boxed area in the inset shows ectopic pancreatic tissue inthe common duct.C and D. H&E stained section through the pancreas (P), duodenum (d) and common duct(arrowhead) of a Sox17Fl/Fl control embryo and a FoxA3cre;Sox17Fl/Fl embryo at E16.5. Thearrowhead points to the common duct, which has pancreatic tissue budding out of the duct inSox17-LOF embryos (D). In both controls and Sox17-LOF, the pancreas (P) and duodenum(d) appear normal.C′-C‴ control and D′-D‴FoxA3cre;Sox17Fl/Fl sections through the common duct stainedwith; the duct specific lectin, DBA (red), insulin plus glucagon (green) and amylase (blue) (C′ and D′); somatostatin (red), insulin (green) and the duct marker, HNF6 (blue) (C″ and D″): or Pdx1 (red), glucagon (green) and HNF6 (blue) (C‴ and D‴). Sox17-LOF ducts haveectopic pancreatic tissue that expresses both exocrine and endocrine markers.

Spence et al. Page 18

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

Figure 4. Sox17 suppresses pancreas development and ventralizes the gutA. Ectopic Sox17 expression in the Pdx1 domain using the Pdx1tTA tetracycline transactivatorsystem. In E10.5 Pdx1tTA;tetO-Sox17 embryos, ectopic Sox17 expression (A′, blue) is seenthroughout the Pdx1 expression domain (A, red). The gall bladder primordium expressesendogenous Sox17 (blue), but not Pdx1 (A″, arrowheads).B, D, and F. Control E10.5 embryos expressing Nkx2.2 and Sox17 (B), HNF6 (D), Hhex andPdx1 (F) protein.C, E and G. Pdx1tTA;tetO-Sox17 embryos at E10.5 expressing Nkx2.2 and Sox17 (C), HNF6(E), Hhex and Pdx1 (G) protein. In Pdx1tTA;tetO-Sox17 embryos, Nkx2.2 expression in thedorsal and ventral pancreatic buds is dramatically decreased and Hhex expression is expandeddorsally (G;arrowheads). Nkx2.2 is still expressed only in areas where tetO-Sox17 is notactivated (C, inset). Inset in F and G shows Pdx1 expression (red).H and I. The transcription factor Ptf1a (green) and Sox17 (blue) in control embryos (H) andin Pdx1tTA;tetO-Sox17 embryos (I). Ptf1a is normally expressed in the presumptive dorsal andventral pancreas, and but ectopic Ptf1a positive cells are also seen in the middle part of the gutof Sox17-GOF embryos, suggesting a patterning defect.J. Schematic of control vs. Sox17-GOF embryos. In control embryos at E10.5, Nkx2.2 (red)is restricted to the dorsal and ventral pancreas whereas Sox17 (blue) is restricted to the gallbladder primordium and Hhex expression (green) is seen in the liver bud, gall bladderprimordium and ventral pancreas. In Sox17-GOF embryos, Sox17 expression is activatedthroughout the Pdx1 expression domain, which results in failure of the dorsal and ventralpancreas to bud, a decrease in Nkx2.2 expression and a dorsal expansion of Hhex into the gutand presumptive dorsal pancreas.

Spence et al. Page 19

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

Figure 5. Sox17 expression is sufficient to induce ectopic ductal tissue, pancreas agenesis and gutmalformations at e16.5A and B. Stomach, duodenum, dorsal and ventral pancreas at E16.5 in control Pdx1tTA (A) andPdx1tTA;tetO-Sox17 (B) embryos. Sox17-overexpressing embryos develop a large mass oftissue at the border between the stomach and duodenum and have only a pancreatic remnant.C and D. H&E stained sections of control (C) Pdx1tTA and (D) Pdx1tTA;tetO-Sox17 embryosat E16.5 showing the stomach, pylorus, and duodenum.E and F. HNF4α protein (red) is in the duodenum and HNF6 protein (green) is in the developingcystic duct (inset) of Pdx1tTA control (E) embryos at E16.5. In Pdx1tTA;tetO-Sox17 (F) embryos

Spence et al. Page 20

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

HNF4α and HNF6 are co-expressed in the epithelium of the ectopic mass and HNF6 isexpressed in ectopic duct-like structures that are found throughout the mass of tissue.G and H. Villin expression is seen in the normal duodenum of Pdx1tTA control (G) andPdx1tTA;tetO-Sox17 (H) embryos. However, the ectopic mass of tissue in Pdx1tTA;tetO-Sox17 embryos contains villin positive intestinal epithelium and villin negative epithelium.

Spence et al. Page 21

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

Figure 6. Use of the Tet-regulatible system shows that Sox17 has distinct temporal activitiesA through F. Sox17 misexpression between e8 and 10.5 causes organ dysgenesis in the Pdx1domain. Following Pdx1tTA mediated activation of the tetO-Sox17 transgene at e8.5 weextinguished transgene expression at e9.5 (D), e10.5 (E), and e12.5 (F) by feeding the animalsdoxycycline (DOX). Control Pdx1tTA embryos developed normally (A, B,C). AllPdx1tTA;tetOSox17 mice (D, E, F) developed a mass and ectopic ducts, indicating thatmaintaining Sox17 for only a short period of time during development is sufficient to suppresspancreas development and cause mis-patterning of the stomach and duodenum.D′ and D″. Adjacent sections of D were immunostained for the molecular markers HNF6(green), Pdx1 (blue) and HNF4α (red) (D′) or glucagon (green), insulin (blue) and villin (red)(D″). A large tissue mass developed in these embryos, and HNF6, Pdx1 and HNF4α was seenin ectopic duct-like structures. Ectopic glucagon and insulin expression was seen in outside ofthe pancreas (P), in between the stomach (S) and duodenum/mass (D).The boxes in D′ and D″ show a magnified view of individual channels in the panels to the right.Arrows and arrowheads point out ectopic glucagon and insulin positive cells, respectively.G and H. Sox17 misexpression in the pancreas from E12.5 results in ectopic ductal tissue atE16.5. E16.5 pancreas from Pdx1tTA control (G) and Pdx1tTA;tetO-Sox17 embryos (H) wheretetO-Sox17 was induced at E12.5 (ectopic Sox17 ON at E12.5). E16.5 control embryos showtypical cords of Pdx1 (green) positive cells interspersed with DBA (red) positive ducts andsurrounded by amylase (blue) positive exocrine pancreas (G). In Pdx1tTA;tetO-Sox17 embryos,cells expressing high levels of Pdx1 are absent and there is a marked increase in DBA positiveducts and a reduction in exocrine pancreas tissue.I and J. Sox17 misexpression in the pancreas from E12.5 results in ectopic ductal tissue in theadult pancreas. Hematoxalin & Eosin staining of adult pancreas from Pdx1tTA controls (I) andPdx1tTA;tetO-Sox17 embryos (J) where tetO-Sox17 was induced at E12.5 (ectopic Sox17 ONat E12.5). Relative to the control pancreas the Pdx1tTA;tetO-Sox17 pancreas has a dramatic

Spence et al. Page 22

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

expansion of ductal tissue at the expense of endocrine and exocrine tissue. The inset in J showsa higher magnification of a region that contains numerous ductal structures.

Spence et al. Page 23

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

Figure 7. Hes1 and Sox17 may act coordinately to segregate the pancreatobiliary primordiaA and B. Dorsal expansion of Sox17-expressing cells in Hes1−/− embryos at E9.5. Sox17 andPdx1 protein in Hes1+/− (A) and Hes1−/− (B) embryos at E9.5. In Hes1+/− embryos Sox17protein (grey) is restricted to the ventral most part of the foregut and Pdx1 protein (red) ishighest in the presumptive ventral pancreas. Hes1 protein (green) is found throughout theventral foregut region and overlaps with both Sox17 and Pdx1. In Hes1−/− embryos (B) Sox17+ cells are expanded dorsally (grey) into the dorsal pancreas (inset, arrows point to ectopicSox17 cells). See Supplemental Fig. S8 for separated color channels.C and D. The Sox17 and Pdx1 expression domains are disrupted in Hes1−/− embryos at E10.5.Sox17, Hhex and Pdx1 protein in Hes1+/− (C) and Hes1−/− (D) embryos at E10.5. In controlembryos (C) Sox17 (blue) and Hhex (green) are expressed in the gall bladder primordium anda Pdx1+ ventral pancreas and gut tube (red). In Hes1−/− embryos (D) the biliary and ventralpancreas are fused (dashed lines) and mostly lack Sox17 (blue) and Pdx1 (red) expression. ThePdx1 expression in D is the gut tube. Scale bars in A-D are 20um.E and F. Hes1 protein is increased in Sox17 gain-of-function embryos. In control e9.5 embryos(E), high Hes1 protein levels are associated with Pdx1/Sox17 co-expressing cells in the ventralforegut. In Pdx1-tTa;tetO-Sox17 embryos, ectopic Sox17 expression in the dorsal bud isassociated with elevated Hes1 levels in Pdx1 + cells (E and F, arrowheads).G and H. Hes1 protein is decreased in Sox17 loss-of-function embryos. Compared to controlE9.5 embryos, Hes1 protein is only observed in a few cells of the ventral gut ofFoxA3cre;Sox17Fl/Fl loss of function embryos (H, arrowheads). For separated Hes1, Pdx1 andSox17 color channels see supplemental figure 9. Pdx1 protein expression is largely unchanged.Scale bars in A-D are 20um.I. A model derived from Sox17 and Hes1 GOF and LOF data showing how Sox17 and Hes1might be part of a regulatory loop.

Spence et al. Page 24

Dev Cell. Author manuscript; available in PMC 2010 July 1.

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript

NIH

-PA Author Manuscript